In addition to editing genes in embryonic kidney cells, CRISPR had been programmed to slice up DNA in human leukemia cells, human stem cells, mouse neuroblastoma cells, bacterial cells, and even one-cell embryos from zebrafish, a popular model organism for genetics studies. CRISPR wasn’t just showing some signs of success; it was exhibiting incredible versatility.
